15d-Prostaglandin J2 Activates Peroxisome Proliferator-Activated Receptor-γ, Promotes Expression of Catalase, and Reduces Inflammation, Behavioral Dysfunction, and Neuronal Loss after Intracerebral Hemorrhage in Rats
Open Access
- 1 June 2006
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 26 (6) , 811-820
Abstract
Peroxisome proliferator-activated receptor-γ (PPARγ) is a transcription factor that regulates the expression of various gene products that are essential in lipid and glucose metabolism, as well as that of the peroxisome-enriched antioxidant enzyme, catalase. Activation of PPARγ is linked to anti-inflammatory activities and is beneficial for cardiovascular diseases. However, little is known about its role in intracerebral hemorrhage (ICH). 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) acts as a physiologic agonist for PPARγ. In this study, we found that injection of 15d-PGJ2 into the locus of striatal hematoma increased PPARγ-deoxyribonucleic acid (DNA) binding activity and the expression of catalase messenger ribonucleic acid (mRNA) and protein in the perihemorrhagic area. Additionally, 15d-PGJ2 significantly reduced nuclear factor-κB (NF-κB) activation and prevented neutrophil infiltration measured by myeloperoxidase (MPO) immunoassay, and also reduced cell apoptosis measured by terminal deoxynucleotide transferase dUTP nick-end labeling (TUNEL). In addition, 15d-PGJ2 reduced behavioral dysfunction produced by the ICH. Altogether, our findings indicate that injection of 15d-PGJ2 at the onset of ICH is associated with activation of PPARγ and elevation of catalase expression, suppression of NF-κB activity, and restricted neutrophil infiltration. All these events predicted reduced behavioral deficit and neuronal damage.Keywords
This publication has 68 references indexed in Scilit:
- Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic StrokeStroke, 2005
- New Horizons for Primary Intracerebral Hemorrhage Treatment: Experience From Preclinical StudiesNeurological Research, 2005
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Peroxisome proliferator‐activated receptors in the cardiovascular systemBritish Journal of Pharmacology, 2000
- Cell surface receptors, nuclear receptors and ligands that regulate adipose tissue developmentClinica Chimica Acta, 1999
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- Regulation of Gene Expression by Fatty Acids and Fibric Acid Derivatives: An Integrative Role for Peroxisome Prolif erator Activated ReceptorsHormone Research, 1992
- Failure of Surgery to Improve Outcome in Hypertensive Putaminal HemorrhageArchives of Neurology, 1990
- Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized studyJournal of Neurosurgery, 1989
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986